not losing weight retatrutide 💉 is the most powerful loss drug ever trialled. 28.7 percent average body weight loss in 68 weeks. Some participants lost over 30 percent of their starting body weight. The Retatrutide, a new weight loss

IMP3 expression is associated with epithelial-mesenchymal transition in breast cancer

BPC-157 works with the body to support: muscle, joint health, digestion and the normal function of the gut-brain axis for whole body resilience

The skin becomes stronger, thicker, and more resilient against future damage

Myers' cocktail, hydration, immune-support (vitamin C + zinc), energy/B-complex, recovery (amino acids + electrolytes), beauty/skin (glutathione + biotin), and NAD+ for cellular energy

If you took Ozempic, Wegovy, Mounjaro, or similar drugs and developed persistent vomiting, gastroparesis, or intestinal issues requiring medical care, you likely qualify

Survodutide (BI 456906) is a GLP-1/glucagon co-agonist which has progressed to phase 3 clinical trials as treatment for obesity (SYNCHRONIZE programme)